HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maha A Moussa Selected Research

iCpG-ODN

3/2022Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maha A Moussa Research Topics

Disease

1Virus Diseases (Viral Diseases)
05/2022
1Infections
05/2022
1Lumpy Skin Disease
05/2022
1Lung Injury
03/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022

Drug/Important Bio-Agent (IBA)

1Lysergic Acid Diethylamide (LSD)IBA
05/2022
1Toll-Like Receptor 9IBA
03/2022
1Caspase 3 (Caspase-3)IBA
03/2022
1iCpG-ODNIBA
03/2022
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022